|
Volumn 44, Issue 9, 2012, Pages 2582-2584
|
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation
a
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
GLUCOSE;
INSULIN;
ORAL ANTIDIABETIC AGENT;
TACROLIMUS;
ADULT;
CHRONIC GRAFT REJECTION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DIABETES MELLITUS;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
GLYCEMIC CONTROL;
HUMAN;
INSULIN TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIPID METABOLISM;
MALE;
NEW ONSET DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
ADULT;
BIOLOGICAL MARKERS;
BLOOD GLUCOSE;
CALCINEURIN;
CHRONIC DISEASE;
CYCLOSPORINE;
DIABETES MELLITUS;
DRUG SUBSTITUTION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
HYPOGLYCEMIC AGENTS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY;
KIDNEY TRANSPLANTATION;
LIPIDS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84869033569
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.09.066 Document Type: Conference Paper |
Times cited : (8)
|
References (5)
|